Recent Updates
Recently added Catalysts
FULC Positive Sentiment

Fulcrum Therapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Monday, May 15, 2023, at 8:00 a.m. ET

Monday, May 8, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, Inc. is set to release its first quarter 2023 financial results on May 15, 2023, before U.S. market opening. The company will host a conference call and webcast at 8:00 a.m. ET to discuss these results and recent corporate developments. Interested individuals can register for the conference call and access a live audio webcast through the company's website.
Price reaction · baseline $2.835 (2023-05-05 close) · clean, no other FULC news in the window
day 0 close
+8.6%
day 1 · peak
+15.3%
day 3
+12.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is releasing its financial results, indicating ongoing business activity.
  • The company continues to focus on patient care through rare disease treatment.
  • Management will provide updates on recent corporate developments during the call.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its first quarter 2023 financial results will be released on Monday, May 15, 2023 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
Individuals may register for the conference call by clicking the link here. Once registered participants will receive a dial and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com
Executive Director, Corporate Communications
Fulcrum Therapeutics, Inc.

Frequently Asked Questions

When will Fulcrum Therapeutics release its Q1 2023 financial results?

The financial results will be released on May 15, 2023, before U.S. markets open.

What time is the conference call for Q1 2023 results?

The conference call will take place at 8:00 a.m. ET on May 15, 2023.

How can one register for the Fulcrum Therapeutics conference call?

Individuals can register by clicking the provided registration link.

Will there be a replay of the conference call?

Yes, an archived replay will be available following the live webcast.

Where can I find the audio webcast for the call?

The audio webcast is accessible on the Investor Relations section of Fulcrum's website.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics Q1 2023 financial results biopharmaceutical
Last updated: May 8, 2023

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →